Novo Nordisk
Offices at Novo Nordisk
Novo Nordisk is headquartered in Hovedstaden, DNK and has 12 office locations.
Hybrid Workplace
Employees engage in a combination of remote and on-site work.
U.S. Office Locations
Global Office Locations
Denmark
With a laboratory completed in 2021 to support analytical and process development, the CMC team works alongside Quality, Regulatory, Technical Operations and RNAi Early Development professionals at our Boulder, Colorado facility and works closely with our teams in Lexington, Massachusetts.
Our Bio Innovation Hub is the headquarters for Global R&D Business Development across all our therapeutic and technology areas. Cambridge reigns as one of the world's top innovation ecosystems, as it is home to leading academic institutions, hospitals, and R&D organizations.
5235 International Drive, Durham, NC, United States, 27712
Located in the heart of the San Francisco Bay Area, Site Fremont is home to the Cell Therapy R&D GMP Manufacturing facility, which is made up of 90+ cell therapy experts who support projects in pre-clinical and clinical development with high quality and fully compliant stem cell-based products.
Focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute to disease.
2476 Argentia Rd #101, Mississauga, Ontario, Canada, L5N 6M1
Our US headquarters plays a critical role in the vibrancy of the life sciences industry. Here we are responsible for sales, marketing and clinical trials management for all Novo Nordisk US products.
Our research centre in Seattle is focused on digital therapy, data science and artificial intelligence. Furthermore, a dedicated team of device engineers are working with digitalisation and connectivity of medical devices for improved treatment outcome.
Our research centre located in Watertown is focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers.
Our West Lebanon, New Hampshire site expands our manufacturing capacity and is focused on hemophilia and growth hormone disorder products.
